Roche Acquires Genia Technologies - - BioPharm International

ADVERTISEMENT

Roche Acquires Genia Technologies


Roche acquired Genia Technologies, a privately held company based in California. Genia is developing a single-molecule, semiconductor based, DNA sequencing platform using nanopore technology. Under the terms of the agreement, Roche will pay Genia's shareholders USD 125 million in cash. In addition to this payment from Roche, Genia's shareholders may receive up to USD 225 million in contingent payments depending on the achievement of certain milestones. Genia's proprietary technology is expected to reduce the price of sequencing while increasing speed and sensitivity.

"The acquisition of Genia is a further step for Roche to introduce a potentially disruptive technology to the market," said Roland Diggelmann, COO of Roche Diagnostics. "The addition of Genia's single molecule semiconductor DNA sequencing platform using nanopore technology strengthens our next generation sequencing pipeline."

Source: Roche

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

AbbVie/Shire Deal Officially Off
October 20, 2014
Amgen Sues Sanofi and Regeneron over Patent for mAb Targeting PCSK9
October 20, 2014
EMA Works to Speed Up Ebola Treatment
October 20, 2014
Lilly to Close Manufacturing Facility in Puerto Rico
October 17, 2014
BioReliance Introduces New Predictive Assays
October 17, 2014
Author Guidelines

Click here